首页> 美国卫生研究院文献>other >Spectrum and Prevalence of CALM1- CALM2- and CALM3-Encoded Calmodulin (CaM) Variants in Long QT Syndrome (LQTS) and Functional Characterization of a Novel LQTS-Associated CaM Missense Variant E141G
【2h】

Spectrum and Prevalence of CALM1- CALM2- and CALM3-Encoded Calmodulin (CaM) Variants in Long QT Syndrome (LQTS) and Functional Characterization of a Novel LQTS-Associated CaM Missense Variant E141G

机译:长QT综合征(LQTS)中的CALM1CALM2和CALM3编码钙调蛋白(CaM)变体的光谱和患病率以及新型LQTS相关的CaM错义变体E141G的功能表征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundCalmodulin (CaM) is encoded by three genes, CALM1, CALM2, and CALM3, all of which harbor pathogenic variants linked to long QT syndrome (LQTS) with early and severe expressivity. These LQTS-causative variants reduce CaM affinity to Ca2+ and alter the properties of the cardiac L-type calcium channel (CaV1.2). CaM also modulates NaV1.5 and the ryanodine receptor, RyR2. All of these interactions may play a role in disease pathogenesis. Here, we determine the spectrum and prevalence of pathogenic CaM variants in a cohort of genetically elusive LQTS, and functionally characterize the novel variants.
机译:背景钙调蛋白(CaM)由三个基因,CALM1,CALM2和CALM3编码,所有这些基因都具有与长QT综合征(LQTS)相关的致病变异,并具有早期和严重的表达能力。这些导致LQTS的变异降低CaM对Ca 2 + 的亲和力,并改变心脏L型钙通道(CaV1.2)的特性。 CaM还可以调节NaV1.5和ryanodine受体RyR2。所有这些相互作用都可能在疾病发病机理中起作用。在这里,我们确定了遗传上难以捉摸的LQTS队列中的致病性CaM变体的光谱和患病率,并在功能上表征了新变体。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号